Effects of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide

This publication has 23 references indexed in Scilit:

• Patterns of ecstasy use in Australia: findings from a national household survey
  Addiction, 2004
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
  Pharmacological Reviews, 2003
• Serotonin Syndrome and Other Serotonergic Disorders: Table 1
  Pain Medicine, 2003
• Dancing with “Death”: P-Methoxyamphetamine Overdose and Its Acute Management
  Journal of Toxicology: Clinical Toxicology, 2003
• Comparative Effects of Substituted Amphetamines (PMA, MDMA, and METH) on Monoamines in Rat Caudate
  Annals of the New York Academy of Sciences, 2002
• Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2000
• Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.
  Psychopharmacology, 1998
• 5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine
  British Journal of Pharmacology, 1993
• Pre-clinical Pharmacology of Moclobemide
  The British Journal of Psychiatry, 1989
• STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN
  Journal of Neurochemistry, 1971